Nkarta (NKTX) Other financing activities (2020 - 2026)

Nkarta's (NKTX) quarterly Other financing activities came in at $6000.0 in Q1 2026, down 90.62% quarter-over-quarter from $64000.0 in Q4 2025.

Nkarta (NKTX) Other financing activities (2020 - 2026) Analysis & Trends

Nkarta's Other financing activities history runs 7 years deep, the most recent figure standing at $6000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities changed N/A year-over-year to $6000.0 in Q1 2026; TTM through Mar 2026 was $147000.0, a 162.55% increase from a year earlier, with the FY2025 full-year figure at $141000.0, down 58.89% from the prior year.
  • Other financing activities retreated to $6000.0 in Q1 2026 per NKTX's latest filing, from $64000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $952000.0 in Q3 2022 and bottomed at -$420000.0 in Q2 2024.
  • The 5-year median for Other financing activities is $78000.0 (2022), against an average of $172642.9.
  • Biggest YoY gain for Other financing activities was 57700.0% in 2024; the steepest drop was 212.6% in 2024.
  • Year by year, Other financing activities stood at $32000.0 in 2022, then surged by 1487.5% to $508000.0 in 2023, then plunged by 63.58% to $185000.0 in 2024, then slumped by 65.41% to $64000.0 in 2025, then sank by 90.62% to $6000.0 in 2026.
  • Per Business Quant, the three latest NKTX Other financing activities figures stand at $6000.0 (Q1 2026), $64000.0 (Q4 2025), and $77000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Nkarta 170.79 Mn 170.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 64,000.00
Dec 31, 2025 64,000.00
Sep 30, 2025 77,000.00
Sep 30, 2025 77,000.00
Dec 31, 2024 185,000.00
Dec 31, 2024 185,000.00
Jun 30, 2024 -420,000.00
Jun 30, 2024 -420,000.00
Mar 31, 2024 578,000.00
Mar 31, 2024 578,000.00
Dec 31, 2023 508,000.00
Dec 31, 2023 508,000.00
Sep 30, 2023 -352,000.00
Sep 30, 2023 -352,000.00
Jun 30, 2023 373,000.00
Jun 30, 2023 373,000.00
Mar 31, 2023 1,000.00
Mar 31, 2023 1,000.00